[b]CERP >>>ROIDAL GAZELLE NEWZZZ//MASSIVE Q1 REVZZZ >>Cereplast Reports Preliminary First Quarter 2013 Revenue Results: Exceeds Revenue for Entire 2012 Fiscal Year[/b]
2013-04-17 08:00 ET - News Release
EL SEGUNDO, Calif., April 17, 2013 (GLOBE NEWSWIRE) -- Cereplast, Inc. (OTCQB:CERP) (the "Company"), a leading manufacturer of proprietary biobased, compostable and sustainable bioplastics, today announced preliminary revenue for the first quarter ended March 31, 2013. Cereplast expects to report 2013 first quarter revenue of approximately $900,000 to $1 million, exceeding total revenue for the entire 2012 fiscal year.
According to management, approximately 65% of this revenue was generated in Italy due to the demand created by the recently published Application Decree, which requires merchants to discontinue the use of traditional single-use plastic bags in favor of bioplastic bags or other alternatives. Sanctions for non-compliance will be enforced beginning the end of May 2013 and management estimates that as a result, the Company will experience an increase in demand for its Cereplast Compostables® blown film resins during the second half of 2013 as merchants are forced to transition to bioplastic alternatives.
Based on certain provisions, including current competition, current production capacity, a full production staff and sufficient working capital, management estimates that the Company's total addressable opportunity for Italy alone exceeds $50 million annually out of a total addressable market for compostable blown film grades in the country that exceeds $500 million per year.
Cereplast Chairman and CEO Mr. Frederic Scheer commented, "We are pleased with our encouraging preliminary revenue results during the first quarter of 2013 and are optimistic for the remainder of 2013. In Italy alone, we conservatively estimate our market opportunity to be approximately $50 million. Additionally, we expect other European nations to enact similar mandates which will exponentially increase our opportunity in Europe. We are excited about these favorable trends and will provide future updates as significant events occur.
About Cereplast, Inc.
Cereplast, Inc. (OTCQB:CERP) designs and manufactures proprietary biobased, sustainable bioplastics which are used as substitutes for traditional plastics in all major converting processes - such as injection molding, thermoforming, blow molding and extrusions - at a pricing structure that is competitive with traditional plastics. On the cutting-edge of biobased plastic material development, Cereplast now offers resins to meet a variety of customer demands. Cereplast Compostables® resins are ideally suited for single-use applications where high biobased content and compostability are advantageous, especially in the food service industry. Cereplast Sustainables® resins combine high biobased content with the durability and endurance of traditional plastic, making them ideal for applications in industries such as automotive, consumer electronics and packaging. Learn more at www.cereplast.com. You may also visit the Cereplast social networking pages at Facebook.com/Cereplast, Twitter.com/Cereplast and Youtube.com/Cereplastinc.
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.
CONTACT: Cereplast, Inc.
Public Relations
Nicole Robertson
(310) 615-1900 x154
nrobertson@cereplast.com
Investor Relations:
Alliance Advisors, LLC
Alan Sheinwald
914-669-0222
asheinwald@allianceadvisors.net
Valter Pinto
914-669-0222 x201
valter@allianceadvisors.net
www.AllianceAdvisors.net
CERP ROIDAL GAZELLE NEWZZZ//MASSIVE Q1 REVZZZ Cereplast
Top 10 Most Recent News Articles
CARsgen's CT1182 Data Opens a Careful New CAR-T Test
Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...
Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle
A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...
Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test
Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...
Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch
By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...
Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach
Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...
Continue Reading
Human Frontier Mission Puts AI Research on Display
A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...
Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint
A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...
Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look
Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...
Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos
A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...
Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims
Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...
Continue ReadingTop 5 Most Recently Viewed Articles
Motorsport Games Achieves Significant Growth in Q3 Results
Motorsport Games Shows Promising Financial Trends Motorsport Games Inc. (NASDAQ: MSGM) recently shared its financial outcomes for the third quarter, reflecting remarkable growth. The company, a key player in the racing game industry, recorded significant advancements, particularly highlighted by their flagship title, Le Mans Ultimate. For Q3 2025, Motorsport Games...
Continue Reading
AI Giants Converge in Singapore for SuperAI 2026
SuperAI Singapore 2026: A Global Gathering Singapore's Marina Bay Sands is buzzing, folks. With 10,000 people crammed into Asia's largest AI event, SuperAI Singapore 2026 is offering up a melting pot of tech brains from 150 countries. It's sold out like your favorite band’s farewell tour—things kicking off with a big bang. A Melting Pot of Innovation You’ve got...
Continue Reading
Investors' Sentiment Towards Terreno Realty Corp Revealed
Understanding Investor Sentiment for Terreno Realty Corp Terreno Realty's short interest has notably surged, reflecting a growing sentiment among investors. Currently, 11.02% increase in short interest reveals that now approximately 6.22 million shares are sold short, making it 10.78% of the float. Observing the trading volume suggests that it would take traders roughly...
Continue Reading
Gilead Sciences Targets Growth Amid Oncology Challenges and Opportunities
Gilead Sciences faced significant challenges back in 2024 as its oncology ambitions faltered, all while the company leaned heavily on its HIV stronghold. The stock stumbled, reflecting broader market jitters about its future growth potential. You see, Gilead had been riding high on Biktarvy, a blockbuster that held nearly 49% of the U.S. HIV treatment market. Analysts...
Continue Reading
Captify Launches Innovative Election War Room Insights 2024
Captify Launches the Election War Room for the 2024 Elections Captify, a leader in real-time audience analytics powered by Search Intelligence, has introduced the Captify Election War Room—a weekly data report that spotlights what people are searching for during the 2024 U.S. election cycle. As the race intensifies, brands and campaign teams want a clearer view of how...
Continue Reading